Literature DB >> 8946003

Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation.

E W Inscho1, A K Cook, L G Navar.   

Abstract

This study was conducted to examine the hypothesis that P2 purinoceptors contribute to pressure-induced autoregulatory adjustments of afferent arteriolar caliber. Experiments were performed in vitro using the blood-perfused juxtamedullary nephron technique. Afferent arteriolar diameter averaged 19.2 +/- 0.6 microns (n = 51) at control perfusion pressure of 100 mmHg and decreased when perfusion pressure was increased. Desensitization of P2 purinoceptors abolished the alpha, beta-methylene ATP-mediated afferent vasoconstriction and prevented pressure-dependent autoregulatory adjustments in afferent diameter. P2-purinoceptor saturation significantly decreased afferent caliber and attenuated pressure-induced autoregulatory responses. To block P2 receptors, afferent arterioles were treated with the P2-purinoceptor antagonists, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid or suramin. P2-receptor blockade prevented the afferent arteriolar vasoconstriction evoked by increasing perfusion pressure from 100 to 130 and 160 mmHg. These data demonstrate that inhibition of P2 purinoceptor-dependent responses through receptor desensitization, receptor saturation, or purinoceptor blockade impairs normal autoregulatory behavior in rat juxtamedullary afferent arterioles. The results are consistent with the hypothesis that P2 purinoceptors participate in mediating autoregulatory adjustments in afferent arteriolar diameter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946003     DOI: 10.1152/ajprenal.1996.271.5.F1077

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  ATP, P2 receptors and the renal microcirculation.

Authors:  Edward W Inscho
Journal:  Purinergic Signal       Date:  2009-03-18       Impact factor: 3.765

Review 3.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

4.  Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.

Authors:  M van der Giet; O Cinkilic; J Jankowski; M Tepel; W Zidek; H Schlüter
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness.

Authors:  J D Imig; J R Falck; E W Inscho
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 6.  Sensing of tubular flow and renal electrolyte transport.

Authors:  Eric H J Verschuren; Charlotte Castenmiller; Dorien J M Peters; Francisco J Arjona; René J M Bindels; Joost G J Hoenderop
Journal:  Nat Rev Nephrol       Date:  2020-03-03       Impact factor: 28.314

Review 7.  Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension.

Authors:  Zhengrong Guan; Edward W Inscho
Journal:  Hypertension       Date:  2011-07-18       Impact factor: 10.190

Review 8.  Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.

Authors:  John D Imig
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-01-17       Impact factor: 3.072

9.  Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.

Authors:  Edward W Inscho; Anthony K Cook; John D Imig; Catherine Vial; Richard J Evans
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice.

Authors:  Hayo Castrop; Yuning Huang; Seiji Hashimoto; Diane Mizel; Pernille Hansen; Franziska Theilig; Sebastian Bachmann; Chuxia Deng; Josie Briggs; Jurgen Schnermann
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.